Protecting kids’ skin from the sun is a priority that extends beyond the summer holidays. According to NHS guidance, children ...

Our panel of 110 parents tested 11 nappy creams to see which were the gentlest on their little one's bottoms. Shop the ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

The FDA pushed back the Prescription Drug User Fee Act action date for ruxolitinib cream (Opzelura) by three months to September 19, 2025. The extension will allow regulators time to review additional ...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the ...

You know how it goes. You look amazing when no one's around, but the second you need to leave the house, your skin has a ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...

Black children in the United States have much higher rates of being diagnosed with eczema than white children, experts say. These disparities in eczema -- also called atopic dermatitis (AD) -- will be ...

Ruxolitinib 0.75% cream and ruxolitinib 1.5% cream are effective and well-tolerated in children aged 2 to 11 years with atopic dermatitis.